Literature DB >> 20726760

Solitary fibrous tumour of the IV ventricle.

Nicola Montano1, Francesco Doglietto, Libero Lauriola, Francesco Signorelli, Roberto Pallini.   

Abstract

BACKGROUND: Solitary Fibrous Tumour (SFT) is a rare tumour occurring mainly in the pleural cavity, with less than 100 cases reported in the Central Nervous System, where it typically presents as a meningeal-based lesion. We describe the case of a SFT located in the fourth ventricle and briefly review the pertinent literature. CASE REPORT: A 61-year-old man presented with a 6-month-history of dizziness, nausea and gait imbalance. Brain magnetic resonance imaging revealed a contrast enhancing, space occupying lesion in the fourth ventricle, with no dural attachment. The patient underwent a sub-occipital craniectomy and total excision of the lesion. Histological examination documented a SFT. The patient is recurrent free at the 2-year follow-up.
CONCLUSION: Although uncommon, SFT should always be included in the differential diagnosis of intraventricular tumours. SFTs of the fourth ventricle are usually benign tumours. Surgery remains the treatment of choice.

Entities:  

Mesh:

Year:  2010        PMID: 20726760     DOI: 10.3109/02688691003675226

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

1.  Fourth ventricular solitary fibrous tumor: a case report and review of the literature.

Authors:  Congli Wang; Varsha Manucha; Scott Faro; Michael Weaver; Abir L Mukherjee
Journal:  J Med Case Rep       Date:  2012-07-17

Review 2.  A solitary fibrous tumor/hemangiopericytoma of the fourth ventricle: case report and literature review.

Authors:  Han Yang; Yuxin Zhang; Ting Zheng; Cao Li; Guangcai Tang; Guangxiang Chen
Journal:  J Int Med Res       Date:  2019-11-17       Impact factor: 1.671

3.  MR imaging of intracranial solitary fibrous tumor: a retrospective study of 7 cases.

Authors:  Yongshan Liu; Qian Wang; Taijuan Zhang; Linlin Yang; Wen Juan Liang
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.